Maen Abdelrahim, MD, PhD, B Pharm

  • Houston Methodist gastrointestinal medical oncologist
  • Assistant Professor of Medicine in Oncology, Houston Methodist Institute for Academic Medicine
  • Director, Houston Methodist Cockrell Center for Advanced Therapeutics
  • Assistant Professor of Medicine, Weill Cornell Medical College

Maen Abdelrahim, MD, PhD, B Pharm

Areas of Expertise

  • Cancer clinical trials
  • Cholangiocarcinoma
  • Clinical research
  • Colon cancer
  • Esophageal cancer
  • Gastric cancer
  • Gastrointestinal stromal tumors (GIST)
  • Liver cancer
  • Neuroendocrine cancers
  • Pancreatic cancer
  • Rectal cancer
  • Small intestine cancer
  • Translation research

Credentials

BACHELOR OF PHARMACY
Isra University - Amman, Jordan
DOCTOR OF PHILOSOPHY
Pharmacology and Toxicology | Texas A&M University - College Station, Texas
MEDICAL SCHOOL
Texas A&M University College of Medicine - Houston, Texas
RESIDENCY
Internal Medicine | Baylor College of Medicine - Houston, Texas
FELLOWSHIP
Medical Oncology | Duke University School of Medicine - Durham, N.C.

Publications

Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma Treated With Liposomal Irinotecan
Yu, KH, Hendifar, AE, Alese, OB, Draper, A, Abdelrahim, M, Burns, E, Khan, G, Cockrum, P, Bhak, RH, Nguyen, C, DerSarkissian, M, Duh, MS & Bahary, N 2021, , Frontiers in Oncology, vol. 11, pp. 678070. https://doi.org/10.3389/fonc.2021.678070

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis
Abdelrahim, M, Mamlouk, O, Lin, H, Lin, J, Page, V, Abdel-Wahab, N, Swan, JT, Selamet, U, Yee, C, Diab, A, Suki, W & Abudayyeh, A 2021, , OncoImmunology, vol. 10, no. 1, 1927313. https://doi.org/10.1080/2162402X.2021.1927313

Incidence, predictors, and survival impact of acute kidney injury in patients with melanoma treated with immune checkpoint inhibitors: a 10-year single-institution analysis
Abdelrahim, M, Mamlouk, O, Lin, H, Lin, J, Page, V, Abdel-Wahab, N, Swan, J, Selamet, U, Yee, C, Diab, A, Suki, W & Abudayyeh, A 2021, , OncoImmunology, vol. 10, no. 1, 1927313, pp. 1927313. https://doi.org/10.1080/2162402X.2021.1927313

Hepatitis B Virus Reactivation in Cancer Patients Treated with Immune Checkpoint Inhibitors
Burns, EA, Muhsen, IN, Anand, K, Xu, J, Umoru, G, Arain, AN & Abdelrahim, M 2021, , Journal of Immunotherapy, vol. 44, no. 3, pp. 132-139. https://doi.org/10.1097/CJI.0000000000000358


New Breakthroughs for Liver Transplantation of Cholangiocarcinoma
McMillan, RR, Saharia, A, Abdelrahim, M & Ghobrial, RM 2021, , Current Transplantation Reports, vol. 8, no. 1, pp. 21-27. https://doi.org/10.1007/s40472-021-00313-6

Infliximab for the treatment of patients with checkpoint inhibitor–associated acute tubular interstitial nephritis
Lin, JS, Mamlouk, O, Selamet, U, Tchakarov, A, Glass, WF, Sheth, RA, Layman, RM, Dadu, R, Abdelwahab, N, Abdelrahim, M, Diab, A, Yee, C & Abudayyeh, A 2021, , OncoImmunology, vol. 10, no. 1, 1877415. https://doi.org/10.1080/2162402X.2021.1877415

A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
Immune Checkpoint Inhibitors in Solid Organ Transplant Consortium 2021, , Kidney international, vol. 100, no. 1, pp. 196-205. https://doi.org/10.1016/j.kint.2020.12.015

Immune checkpoint inhibitor associated reactivation of primary membranous nephropathy responsive to rituximab
Lin, JS, Wang, DY, Mamlouk, O, Glass, WF, Abdelrahim, M, Yee, C & Abudayyeh, A 2020, , Journal for immunotherapy of cancer, vol. 8, no. 2, e001287. https://doi.org/10.1136/jitc-2020-001287

Commentary on Neoadjuvant Versus Surgery First Approach in Resectable Pancreatic Ductal Adenocarcinoma
Saharia, A, Potter, L, Baio, F, Elshawwaf, M, Abdelrahim, M & Heyne, K 2020, , American Journal of Clinical Oncology: Cancer Clinical Trials, vol. 43, no. 10, pp. 753-754. https://doi.org/10.1097/COC.0000000000000743

Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients
Abudayyeh, A, Lin, H, Abdelrahim, M, Rondon, G, Andersson, BS, Martinez, CS, Page, VD, Tarrand, JJ, Kontoyiannis, DP, Marin, D, Oran, B, Olson, A, Jones, R, Popat, U, Champlin, RE, Chemaly, RF, Shpall, EJ & Rezvani, K 2020, , Transplant Infectious Disease, vol. 22, no. 5, e13395. https://doi.org/10.1111/tid.13395

Renal Replacement Therapy in Patients With Stage IV Cancer Admitted to the Intensive Care Unit With Acute Kidney Injury at a Comprehensive Cancer Center Was Not Associated With Survival
Abudayyeh, A, Song, J, Abdelrahim, M, Dahbour, I, Page, VD, Zhou, S, Shen, C, Zhao, B, Pai, RN, Amaram-Davila, J, Manzano, JG, George, MC, Yennu, S, Mandayam, SA, Nates, JL & Moss, AH 2020, , American Journal of Hospice and Palliative Medicine, vol. 37, no. 9, pp. 707-715. https://doi.org/10.1177/1049909120902115

Checkpoint inhibitor-related renal vasculitis and use of rituximab
Mamlouk, O, Lin, JS, Abdelrahim, M, Tchakarov, AS, Glass, WF, Selamet, U, Buni, M, Abdel-Wahab, N & Abudayyeh, A 2020, , Journal for immunotherapy of cancer, vol. 8, no. 2. https://doi.org/10.1136/jitc-2020-000750

Acquired haemophilia as a paraneoplastic manifestation of pancreatic cancer
Arain, A, Muhsen, IN & Abdelrahim, M 2020, , ecancermedicalscience, vol. 14, 1053. https://doi.org/10.3332/ECANCER.2020.1053

Correction to: Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer (Cancer Chemotherapy and Pharmacology, (2020), 85, 3, (621-626), 10.1007/s00280-020-04037-9)
Babiker, HM, Milhem, M, Aisner, J, Edenfield, W, Shepard, D, Savona, M, Iyer, S, Abdelrahim, M, Beach, CL, Skikne, B, Laille, E, Tsai, KT & Ho, T 2020, , Cancer Chemotherapy and Pharmacology, vol. 85, no. 5, pp. 1009-1010. https://doi.org/10.1007/s00280-020-04056-6

Renal Toxicity
Abdelrahim, M & Abudayyeh, A 2020, . in Advances in Experimental Medicine and Biology. vol. 1244, Advances in Experimental Medicine and Biology, vol. 1244, Springer, pp. 287-293. https://doi.org/10.1007/978-3-030-41008-7_16

Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
Babiker, HM, Milhem, M, Aisner, J, Edenfield, W, Shepard, D, Savona, M, Iyer, S, Abdelrahim, M, Beach, CL, Skikne, B, Laille, E, Tsai, KT & Ho, T 2020, , Cancer Chemotherapy and Pharmacology, vol. 85, no. 3, pp. 621-626. https://doi.org/10.1007/s00280-020-04037-9

Impact of autologous stem cell transplantation on long term renal function and associated progression-free and overall survival in multiple myeloma
Abudayyeh, A, Lin, H, Mamlouk, O, Abdelrahim, M, Saliba, R, Rondon, G, Martinez, CS, Delgado, R, Page, V, Rajasekaran, A, Sanders, PW & Qazilbash, M 2020, , Leukemia and Lymphoma, vol. 61, no. 13, pp. 3101-3111. https://doi.org/10.1080/10428194.2020.1797719

Early experience with COVID-19 and solid organ transplantation at a US high-volume transplant center
Yi, SG, Rogers, AW, Saharia, A, Aoun, M, Faour, R, Abdelrahim, M, Knight, RJ, Grimes, K, Bullock, S, Hobeika, M, McMillan, R, Mobley, C, Moaddab, M, Huang, HJ, Bhimaraj, A, Ghobrial, RM & Gaber, AO 2020, , Transplantation, vol. 104, no. 11, pp. 2208-2214. https://doi.org/10.1097/TP.0000000000003339

Is Surgery-first Still a Reasonable Option in the Era of Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer?
Saharia, A, Potter, LM, Baio, F, Elaileh, A, Mobley, C, Ghobrial, RM, Abdelrahim, M & Heyne, K 2019, , American journal of clinical oncology. https://doi.org/10.1097/COC.0000000000000661

Languages

  • English
  • Spanish